These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Dipyrone and agranulocytosis: what is the risk? Schönhöfer P; Offerhaus L; Herxheimer A Lancet; 2003 Mar; 361(9361):968-9. PubMed ID: 12648993 [No Abstract] [Full Text] [Related]
25. The incidence of metamizole sodium-induced agranulocytosis in Poland. Maj S; Lis Y J Int Med Res; 2002; 30(5):488-95. PubMed ID: 12449518 [TBL] [Abstract][Full Text] [Related]
26. [Benefit-risk considerations in metamizole treatment. Rational recommendations for indications and contra-indications according to current knowledge]. Ell C; Domschke S; Domschke W Fortschr Med; 1982 Apr; 100(14):615-8. PubMed ID: 7084847 [No Abstract] [Full Text] [Related]
27. Drug-induced agranulocytosis. A survey of twenty-three episodes. Mintz U; Shaklai M; Pinkhas J; de Vries A Med Interne; 1975; 13(3):205-8. PubMed ID: 52883 [TBL] [Abstract][Full Text] [Related]
28. [Agranulocytosis and septic shock after metamizole use]. Oude Munnik TH; Annink-Smoors M; Hom HW; Sportel ET Ned Tijdschr Geneeskd; 2016; 160():A9464. PubMed ID: 26840935 [TBL] [Abstract][Full Text] [Related]
29. In vitro generation of cytotoxic lymphocytes during noramidopyrine-induced agranulocytosis. Gualde N; Malinvaud G Clin Immunol Immunopathol; 1982 Aug; 24(2):220-6. PubMed ID: 6214354 [No Abstract] [Full Text] [Related]
30. Do we continue to prescribe dipyrone (analgin)? Bharani AK; Mehta RS; Sanghvi VC J Assoc Physicians India; 1984 Apr; 32(4):382-3. PubMed ID: 6746560 [No Abstract] [Full Text] [Related]
31. [17-year-old patient with neutropenia and fever during therapy with analgesics]. Pfersdorff M; Spes J; Kraus MR Dtsch Med Wochenschr; 2011 Feb; 136(8):365-8. PubMed ID: 21332035 [TBL] [Abstract][Full Text] [Related]
32. A new concept in the relationship between biochemical reaction mechanisms and molecular basis of agranulocytosis. Akintonwa DA Biochem Med; 1984 Oct; 32(2):151-60. PubMed ID: 6210079 [TBL] [Abstract][Full Text] [Related]
33. [Surgery, dipyrone, and agranulocytosis in Latin America]. Sánchez Medal L Sangre (Barc); 1997 Oct; 42(5):343-4. PubMed ID: 9424731 [No Abstract] [Full Text] [Related]
34. Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data. Klose S; Pflock R; König IR; Linder R; Schwaninger M Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):681-690. PubMed ID: 31811328 [TBL] [Abstract][Full Text] [Related]
35. [Treatment of drug-induced agranulocytosis with granulocyte colony stimulating factor (G-CSF) in a surgical intensive care unit]. Huss B; Bogosyan S; Müller E; Götz E Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Oct; 31(8):529-30. PubMed ID: 9019189 [TBL] [Abstract][Full Text] [Related]
36. [Severe thrombocytopenia and agranulocytosis associated with metamizole]. Fernández García PL; Ibáñez Camacho MF; López Pérez E Med Clin (Barc); 2016 Oct; 147(8):e43-e44. PubMed ID: 27450174 [No Abstract] [Full Text] [Related]
37. [Incidence and probable etiology of toxic agranulocytosis in a definite population in the province of Buenos Aires (1963-1976)]. Larregina A; Aggio MC; Alvarez RV Medicina (B Aires); 1994; 54(1):13-6. PubMed ID: 7990680 [TBL] [Abstract][Full Text] [Related]
38. Bone marrow colony-forming cells in acute drug-induced agranulocytosis. Coiffier B Biomedicine; 1978 May; 29(3):108-11. PubMed ID: 28794 [TBL] [Abstract][Full Text] [Related]
39. [Fatal agranulocytosis after metamizole reexposure]. Zeiner E; Blaser LS; Tisljar K; Heim D; Taegtmeyer A Praxis (Bern 1994); 2015 Jan; 104(3):151-4. PubMed ID: 25626384 [TBL] [Abstract][Full Text] [Related]